We employ the modern medicinal chemistry techniques (combinatorial chemistry, in silico design and construction of chemical libraries, solid phase synthesis, drug delivery methods,…) for the identification of hit compounds against targets of pharmacological interest. Complementarily, the chemical modulation of these hits for their conversion into lead compounds for further development in collaboration with pharma and biotech companies is intensively pursued. Group leader: Prof. Angel Messeguer.